Company intelligence / Profile preview
MitoChem Therapeutics
Charleston, South Carolina, United Statesmitocheminc.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
The company has developed a novel class of small molecules that protect mitochondria from dysfunction. Their lead compound shows promising preclinical efficacy across multiple animal models for rare and common neurodegenerative and metabolic diseases. Early toxicology data are favorable. The lead program targets retinitis pigmentosa with orphan drug status granted by FDA.[4]
- Therapeutic areas
- OphthalmologyCardiovascularNeurologyMetabolic Disorders
- Modalities
- Small molecules designed to treat mitochondrial dysfunction[4][6]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations/funding from Foundation Fighting Blindness and NIH; no major pharma partnerships explicitly listed but pursuing institutional investment and partnerships to advance pipeline.[2][4][6]
Beyond the preview
Go deeper on MitoChem Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MitoChem Therapeutics.